Objective: To determine outcomes of patients undergoing a bidirectional cavo-pulmonary shunt (BCPS) in the Fontan era. Methods: From 1990 to 2000, 212 patients underwent a BCPS in a single institution at a mean age of 2.6 AE 5 years. Results: Hospital mortality was 6% (13 patients). Five patients were lost to follow-up (3%). After a mean of 9 AE 4 years, 15 patients had not yet been referred for Fontan surgery and their status was deemed satisfactory (11 1½ ventricle repair, three BCPS and one patient converted to a bi-ventricular repair). Out of the remaining 179 patients who could potentially have reached a Fontan status, 141 had undergone the procedure and seven were awaiting Fontan completion. The expected completion rate of Fontan surgery after BCPS was 83% (148/179). Thirteen patients died and heart transplantation was necessitated in nine patients. Nine were deemed unsuitable for Fontan surgery for cardiac (seven), respiratory (one) or neurologic (one) reasons. After BCPS, the only predictors of late failure (death, heart transplantation or NYHA class III-IV) were not reaching Fontan status and the presence of bilateral superior vena cava (SVC). Ten-year survival was 99% (95% confidence interval (CI): 95-99%) for Fontan patients and 67% (95%CI: 50-80%) for those left with a BCPS. Conclusion: In the present era, staging with BCPS represents a selection process in the Fontan pathway. Almost a fifth of the patients will not reach Fontan status. Outstanding results after Fontan surgery may hide a high attrition rate between BCPS and Fontan. #
Introduction
In 1988, the first modification of the original Fontan procedure, the lateral tunnel or total cavo-pulmonary connection was proposed by de Leval et al., and in the early 1990s, most centres adopted the technique [1] . This modification of the original design of the Fontan procedure had initially been introduced to reduce turbulences and energy losses in the venous pathway. As the technique included an anastomosis between the superior vena cava (SVC) and the right pulmonary artery, it had the additional advantage that it revived the interest in cavo-pulmonary anastomosis, and opened the possibility of staging. Soon thereafter, the feasibility of staging with a bidirectional cavo-pulmonary shunt (BCPS), and its potential benefits were demonstrated [2] [3] [4] [5] [6] [7] [8] . At the time, it was hypothesised that staging would allow a better intermediate palliation before Fontan, allowing better systemic oxygenation of the patients, with less volume loading of their single ventricular cavity, and that staging would increase Fontan candidacy among potential patients. Staging was rapidly embraced by the surgical community, before this latter hypothesis was truly tested. Today, most of the long-term outcomes after cavo-pulmonary surgery still emanate from the period when the classical Glenn shunt was extensively performed, before the Fontan era. Excellence of results is now the standard outcome after Fontan surgery, but little is known of the outcomes of the patients undergoing its intermediate step.
Patients and methods
The design of the study was approved by the local hospital ethics and human research committee. The records of all consecutive patients undergoing a BCPS as a staging procedure, from 1990 to 2000 were reviewed, and their follow-up obtained from their referring cardiologists. Twenty-seven overseas patients were excluded, bringing the cohort of Australian patients down to 212.
Patients
Patients' characteristics are displayed in Table 1 . The distribution of non-cardiac abnormalities among the cohort are as follows: asplenia (eight), heterotaxy (one), cerebral palsy (two), Down's syndrome (one), haematological disorders (two), caudal regression syndrome (one), quadriparesis (one), Wolff-Parkinson-White syndrome (one), HoltOram syndrome (one), VATER syndrome (one), hemiplegia (two), epilepsy (two), Chiari malformation (one), Soto syndrome (one), facial dysmorphia (two), spina bifida occulta (one), thoracic hemivetebrae (one) and severe deafness (one). Before BCPS, 152 patients (71%) required some adjustment of their pulmonary blood flow. A total of 130 patients (61%) had a preoperative catheterisation study. The mean pulmonary artery pressure, recorded in 59 patients, was 15.8 AE 4.5 mmHg. Aortic saturation was available in 79 patients and moderate-to-severe atrio-ventricular valve regurgitation was identified in 24 patients (11%).
Surgical procedures
Two-thirds of the patients (142/212) were operated upon before the age of 1 year. All procedures were performed under cardiopulmonary bypass. In all patients, the superior vena cava was separated from the atrium, and the atrial end of the superior vena cava sutured. The superior vena cava was then anastomosed to an opening made in the right pulmonary artery. All but two patients, who had bilateral venae cavae, underwent a bilateral BCPS: one patient with bilateral superior vena cava had a hypoplastic left superior vena cava ligated and in another patient, both the vein and the left pulmonary artery were estimated to be too hypoplastic to perform a BCPS on that side.
In 58 patients, according to the surgeon's preference, the main pulmonary artery was left patent, and some forward flow was kept between a ventricular chamber and the pulmonary arteries. A total of 105 patients underwent the following 135 procedures at the time of the BCPS: atrial septectomy (26), valve repair (20) , valve replacement (one), Damus procedure (16), repair of totally anomalous pulmonary venous drainage (five), relief of subaortic stenosis (five), relief of right ventricular outflow tract obstruction (two), systemico-pulmonary shunts (two), pulmonary artery banding (17) , pulmonary artery reconstruction (20) and other (21).
Statistical analysis
Hospital mortality was defined as death within 30 days or before hospital discharge. Failure was defined as death, heart transplant or NYHA class III or IV.
All pre-and perioperative variables listed in Table 2 were tested by univariate analysis for their impact on hospital mortality. Significant variables were then entered in a multiple logistic regression analysis. Kaplan-Meier curves were obtained for temporal outcomes, survival and failure. All perioperative variables were tested for their impact on these outcomes by univariate Cox regression analysis (Breslow method for ties), and all factors shown to have a significant effect were then entered in a multiple Cox regression in a stepwise fashion.
Continuous data were expressed as mean AE standard deviation or median (interquartile range). Categorical data were expressed as frequency (percentage). Proportions were compared with chi-square analysis. Continuous outcomes with binary variables were compared using Student's t-test for normally distributed data and Wilcoxon's rank-sum test for skewed data. A p value of <0.05 was considered statistically significant. All statistical analyses were performed using Stata version 10.0 (Stata Corp, College Station, TX, USA). 
Results

Hospital mortality and morbidity
There were 13 hospital deaths (6%). Nine of these deaths were due to low output syndrome, two due to ventricular arrhythmia and one due to pneumonia. In two of the patients dying of low output syndrome, the BCPS was taken down on the first operative day and a systemico-pulmonary shunt reconstructed. The remaining patient died of a postoperative cerebral haemorrhage.
Twenty-nine patients had the following postoperative complications: five had a complete heart block requiring a pacemaker implantation (two hospital deaths), three had a phrenic nerve palsy requiring diaphragm plication (two hospital deaths), seven had prolonged drainage of a chylothorax (one hospital death), two had a pericardial effusion requiring drainage (one hospital death), two had a haemothorax requiring chest re-exploration (one hospital death), five had sustained prolonged arrhythmias (two hospital deaths), two required a prolonged inotropic support, two underwent debridement for a deep wound infection (one hospital death) and one had a peripheral arterial thrombosis.
By univariate analysis, only younger age at operation predicted mortality ( p < 0.05).
Late survival
Five patients were lost to follow-up, all of them before Fontan completion. Completeness of follow-up was 96.8%, while concurrent completeness of follow-up was 91.6% (2004) (2005) (2006) (2007) (2008) .
After a mean follow-up of 9.1 AE 4.4 years, there had been a total of 17 late deaths. Death occurred after a median of 1.6 (0.7-4) years following BCPS. Thirteen patients died with a BCPS status. Two deaths occurred after re-operations. One patient underwent a main pulmonary artery ligation 2 months after a Kawashima procedure. He ultimately succumbed to heart failure with severe mitral valve regurgitation. The other patient died after an atrio-ventricular valve replacement performed 4 years after BCPS. The remaining causes of late death were heart failure (five), sudden death (four) and pneumonia (two).
Nine of the patients surviving BCPS, deemed unsuitable for Fontan surgery, were successfully transplanted. Three of these transplanted patients died 1, 9 and 12 years after transplantation. One patient died suddenly 1 year after Fontan surgery.
Interim mortality between BCPS and Fontan was 7% (13/ 199) and risk of heart transplantation was 5% (9/199).
The morphological characteristics of patients suffering late deaths were as follows: complete atrio-ventricular septal defect (five), tricuspid atresia (three), double outlet right ventricle (two), double inlet left ventricle (two), hypoplastic left ventricle (three) and complex anatomy (two). In addition, five patients had atrial isomerism, six possessed bilateral superior vena cavae and five had interrupted inferior vena cavae. Finally, two patients had moderate-to-severe atrio-ventricular regurgitation prior to BCPS, and five had preoperative mean pulmonary artery pressures above 15 mmHg.
Late re-operations
Twenty-four patients underwent re-operations before reaching Fontan status at a median of 4 years (1-8 years) after BCPS. One patient remained oxygen dependent and required repeated pleural effusion drainages. He ended up undergoing a repair of an atrio-ventricular septal defect and double outlet right ventricle 48 months after BCPS. The remaining procedures were: valve repair (four), valve replacement (two), septal defect closure (two), aortic arch repair (one), left modified Blalock-Taussig shunt (three), PA band tightening (seven), valve closure (two), total anomalous pulmonary venous drainage (TAPVD) repair (three), creation of AV fistula (one), subaortic membrane resection (one), right ventricular outflow tract (RVOT) resection (one), ligation of main pulmonary artery (one) and insertion of a pacemaker (one).
Late status and Fontan completion rate
In 14 patients, BCPS was considered as the last form of palliation, not requiring Fontan surgery by the referring cardiologist: 11 after a 1½ ventricle repair, and three patients on a BCPS with a significant forward flow between their ventricular cavity and the pulmonary arteries. The patient who was taken down to a bi-ventricular repair was not considered a candidate for Fontan palliation.
Out of the 194 hospital survivors followed up, 179 were therefore potential candidates for Fontan completion. Nine patients were deemed unsuitable for Fontan surgery for cardiac (seven), respiratory (one) or neurological (one) (13), heart transplantation (nine) or unsuitability (nine). The rate of expected Fontan completion among potential candidates after BCPS was thus 83% (148/ 179).
Survival analysis
Kaplan-Meier survival of the population of patients surviving the hospital stay was 90.7% at 10 years (95% confidence interval (CI) 85.1-94.3%) and 88.7% at 15 years (95% CI: 81.4-93.3%). Using multivariate analysis, not reaching Fontan status, having a bilateral superior vena cava and suffering hospital morbidity were predictive of late mortality ( Table 3 ). The 10-year survival was 99.2% (95% CI: 94.7-99.9%) for the patients who had progressed to Fontan, and 67.4% (95% CI: 49.7-80%) for those remaining on a BCPS status (Fig. 1) . Comparative patients' characteristics between patients reaching Fontan status and those who remained on a BCPS are shown in Table 4 .
Late failure
Twenty-nine patients were considered to have a failure of their BCPS circulation because of late death (14) , heart transplantation (nine) or being at the previous follow-up in NYHA class III (five) or IV (one). The 15-year freedom from failure for the entire population was 78.2% (95%CI: 67.4-85.8%). Using multivariate analysis, not reaching Fontan status and having a bilateral SVC were identified as independent predictors of late failure (Table 5 ). Freedom from failure at 10 years was 99.2% (95% CI: 94.4-99.9) for the Fontan group and 67.4% (95% CI: 49.7-80%) for the BCPS patients (Fig. 2) .
Discussion
Today, the excellence achieved in Fontan surgery may deceive the clinician into believing that mortality has globally decreased in the univentricular heart pathway leading to Fontan [9] . Staging with BCPS has been demonstrated to be beneficial to these patients, because volume offloading of these univentricular hearts at an earlier age may prevent the development of the diastolic dysfunction adversely affecting the Fontan circulation. As this staging is so obviously beneficial to the patients, it was intuitively thought that staging would also increase the proportion of patients becoming adequate Fontan candidates. The low levels of hospital mortality after BCPS and the Fontan procedure may mask the reality that some of these patients may still die in the interim, they remain palliated with a BCPS because they are deemed to be poor Fontan candidates, or be directed to heart transplantation. There is surprisingly little information on these outcomes. Most of the reported mid-to long-term outcomes after cavo-pulmonary connections arise from the pre-Fontan era [2, 10] . The subsequent studies on outcomes after BCPS focussed on hospital and mid-term survival and their associated risk factors. Late survival after BCPS seems to hover around 85% at 10 years and 65% at 20 years. Because the patients reviewed were not systematically entered in a staging to Fontan policy, none of these studies was able to determine the probability of reaching Fontan status after BCPS [11] [12] [13] [14] [15] . Only the study of Tanoue specifically examined this outcome in 333 patients operated between 1992 and 2004 [16] . Their interim mortality was 7%. They expected their Fontan completion rate to be 89%, but at the time of their publication only 69% had received a Fontan.
In our institution, we initiated a staged approach to Fontan procedure for patients with univentricular hearts in 1990. We designed the present study with the aim to specifically evaluate the outcomes of BCPS as a staged procedure during a period when the operated patients were ultimately expected to have undergone the final Fontan, and we believe that it gives a clearer view of realistic expectations for patients operated upon in that era.
The hospital mortality suffered in this patient population was higher than what would be expected currently [14, 16] . A mortality of 6% compares favourably to the numbers of 6-13% quoted in the series from the 1990s [4, 11, 12, 15] . This higher mortality probably reflects our learning experience in patient selection and in the postoperative management of this difficult population. While the better survival of older patients probably reflects a natural selection process, this finding is of little clinical relevance, because delaying the procedure would defeat the purpose of offloading these single ventricles early in life. Sustaining postoperative complications greatly increased late mortality. Once the patients had undergone a Fontan procedure, they were destined to a much better future. However, one should not use this fact as an argument when comparing outcomes between patients left with a BCPS status and those who have undergone Fontan surgery. Some have argued that a Fontan circulation would not be superior to a BCPS supplemented with some additional source of blood flow [17] [18] [19] . As most of the patients in this series were expected to proceed to Fontan surgery, the present study should not be used to compare these two statuses, because, in this setting, all the mortalities were automatically attributed to the group with a BCPS circulation. Patients with bilateral SVCs had a greater risk of dying or failing during follow-up. This specific fact had already been demonstrated in previous studies, and had been attributed to thrombus formation in the central pulmonary arteries of these patients [20, 21] . In our group, having a bilateral SVC was clearly related to heterotaxy as evidenced in the comparison between the patients undergoing Fontan surgery and those remaining on a BCPS status. Worse prognosis has repeatedly been associated with heterotaxy syndromes [12, [22] [23] [24] .
The estimation of the interim mortality and the Fontan completion rate varies if hospital mortality is taken into consideration in the calculation. It is nonetheless clear that only 141 patients from our initial 212 patient population finally underwent Fontan surgery, in a time frame when most would have expected to have gone through to this final stage. Even if one discards the hospital mortalities, hoping that this number has improved over time, our patients still suffered 7% interim mortality, a 5% risk of requiring heart transplantation and a 5% chance of being refused Fontan surgery. We recently reported no hospital mortality and an excellent outcome 15 years after Fontan surgery in our patients operated upon between 1990 and 2000 [9] . It is now clear that staging with BCPS, introduced in our centre in 1990, may have improved diastolic function and the functional status of our patients awaiting Fontan surgery; however, it definitely introduced a tighter selection process before Fontan surgery. It points out that teams who are more selective in their indication for Fontan surgery will report better results for this surgery. To be relevant, the report of outcomes of patients born with single ventricle pathology and the assessment of the quality of Fontan surgery should include the result of the intermediate stages, leading to Fontan status.
Limitations
The findings of the study are obviously limited by the historical nature of this series, reflecting the results of staging with BCPS in an earlier era. Thus, they may not reflect today's accomplishments.
In conclusion, in the present era, staging with BCPS constitutes a selection process in the pathway to Fontan. Almost a fifth of the patients will not reach Fontan status. Outstanding results after Fontan surgery may hide a high attrition rate between BCPS and Fontan.
